Floatz logo

Etoposide

Small Intestine Lymphoma

Fred Hutchinson Cancer CenterSmall moleculePhase 2Dormant
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Small Intestine Lymphoma cohort.

Asset / SponsorPhaseRating
Fludarabine
Case Comprehensive Cancer Center
Phase 2BBB
Cyclophosphamide
University of Chicago
Phase 2BBB
Rituximab
Mayo Clinic
Phase 2BBB
Dexasone
Mayo Clinic
Phase 2BBB
Cyclosporin A
National Cancer Institute (NCI)
Phase 2BB

View all 50 →

Same molecule, other indications

Etoposide is also rated in:

acute megakaryoblastic leukemiaDormant
BBB
Indicative · Phase 3
79 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative · Phase 3
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative · Phase 3
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →